Richard Scarrott

Richard Scarrott has a strong background in finance and business management. Richard most recently served as the Chief Financial Officer at SiSaf Ltd, a company focused on RNA therapeutics. Prior to that, they held various positions at HIPPO™, including Finance and Commercial Director, Finance Director and COO, and Finance Director. Richard also worked as the Chief Financial Officer at Norwood Immunology Limited, an AIM listed biotech group. Earlier in their career, they worked as a Consultant at RJS Associates, advising pharma and healthcare companies on business plans and strategy. Richard began their career at Arthur Andersen, where they spent 14 years in Corporate Finance, specializing in mergers and acquisitions and fundraising.

Richard Scarrott completed their Bachelor of Science degree with honors in Management and Business at Aston University from 1986 to 1990.